The 1st Annual SOPS Conference 2026, organized by the Saudi Oncology Pharmacy Society (SOPS), is a premier scientific gathering dedicated to advancing oncology pharmacy practice across Saudi Arabia and the MENA region.
Taking place on 3–4 April 2026 in Riyadh, the conference brings together oncology pharmacists, clinical pharmacists, hematologists, oncologists, researchers, and healthcare leaders for two days of high-impact scientific exchange and professional development.
Day 1 features a comprehensive scientific program including panel discussions on SOPS Oncology Pharmacy Practice Competency Based Certification, Innovation at the Core of Evolving Oncology Pharmacy Practice in the MENA region, and SOPS Picks sessions covering T lymphoblastic lymphoma/leukemia, myeloma care, CLL management, hemophilia management, HER2 breast cancer, biomarker-driven lung cancer treatment, CRC frontier therapies, and immunotherapy breakthroughs in bladder cancer.
Day 2 offers two post-conference workshops: Workshop 1 on 'Evaluating Value in Oncology: Methodological Considerations in Clinical and Economic Assessment' and Workshop 2 on 'Managing Infectious Diseases in Immunocompromised Patients: Clinical, Diagnostic, and Therapeutic Challenges.'
The conference is accredited for 6 CME hours (Day 1) and 4 CME hours (Day 2 workshops), totaling 10 CME hours.
Target audience includes Oncology Pharmacists, Clinical Pharmacists, Pharmacy Technicians, Medical Oncologists, Hematologists, Oncology Nurses, Pharmacy Residents, Faculty Members, Researchers, Healthcare Administrators, Regulators, and Pharmaceutical Industry Professionals.
